Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.12
+0.10 (1.66%)
Dec 31, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $142.25 million as of December 31, 2025. Its market cap has decreased by -15.51% in one year.
Market Cap
142.25M
Enterprise Value
125.32M
1-Year Change
-15.51%
Ranking
Category
Stock Price
$6.12
Market Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $142.25M, a decrease of -6.49%. That is a compound annual growth rate of -4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |